Merdury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 5.51
+0.02 (0.36%)
Aug 19, 2026, 12:55 PM CST
Merdury Biopharmaceutical Market Cap
Merdury Biopharmaceutical has a market cap or net worth of 2.29 billion as of August 19, 2026. Its market cap has decreased by -37.02% in one year.
Market Cap
2.29B
Enterprise Value
2.19B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.51
ChartMarket Cap Chart
Since December 23, 2022, Merdury Biopharmaceutical's market cap has decreased from 5.10B to 2.29B, a decrease of -55.18%. That is a compound annual growth rate of -19.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 2.29B | -34.14% |
| Dec 31, 2025 | 3.47B | -36.83% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Panion & Bf Biotech | 5.02B |
| Orient EuroPharma | 4.27B |
| LIWANLI Innovation | 3.92B |
| Tien Liang BioTech | 3.81B |
| Easywell Biomedicals | 3.76B |
| Yoda Pharmaceuticals | 3.57B |
| Maywufa Company | 2.78B |
| Johnson Chemical Pharmaceutical Works | 2.48B |